
    
      To investigate if dapagliflozin improves nocturnal substrate oxidation expressed as
      respiration quotient (RQ) during the sleeping period in comparison with placebo after 2-weeks
      double blind treatment in subjects with a disrupted glucose homeostasis.
    
  